primary care survey (survey link)
.conlive1 A:link {color: #144892; font-size: 14px;}.conlive1 A:visited {color: #144892; font-size: 14px;}.conlive1 A:active {color: #144892;font-size: 14px;}.conlive1 A:hover {text-decoration: underline; color: #144892; font-size: 14px;}
Thank you for registering to ConsultantLive.com.
Click here to participate in the survey
Offer Terms: Offer available only to licensed physicians who register as members of ConsultantLive.com prior to October 15, 2010, subject to UBM Medica's verification of member's licensure status. Registrants must be (i) legal residents of the fifty United States (and the District of Columbia), (ii) at least 18 years of age, and (iii) licensed physicians, as of the date of their registration. Employees of UBM Medica, its parent company, affiliates and subsidiaries, and their agents, subcontractors, suppliers, as well as the immediate family (spouse, parents, siblings, and children) and household members of each such employee are not eligible to receive incentive. Limit 1 gift card per person. Offer is not retroactive to previously registered members. The gift card code will be e-mailed to you within 7 - 10 business days of October 15, 2010 at the e-mail address on file with UBM Medica (in user’s member profile). E-mail address on file must be a valid, working e-mail address in order to receive incentive.
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.